NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi
Covered in this story
Call it yourself
No calls on $NEO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Neogenomics Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.